MedPath

A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy

Not Applicable
Recruiting
Conditions
IVF
Frozen Embryo Transfer
Interventions
Procedure: Immediate FET
Procedure: Delayed FET
Registration Number
NCT04371783
Lead Sponsor
ShangHai Ji Ai Genetics & IVF Institute
Brief Summary

This randomized trial we aim to compare the live birth rate of immediate versus delayed FET replacing a single blastocyst in the first FET of the first stimulated IVF cycle following. The hypothesis is that the live birth rate of the immediate FET is higher than the delayed FET replacing a single blastocyst in the first FET of the first stimulated IVF cycle following a freeze-all strategy. Women will undergo IVF/ICSI in the centre as clinically indicated. Standard ovarian stimulation with gonadotrophins in a Gonadotrophin releasing hormone (GnRH) antagonist protocol will be employed. Hormone replacement treatment (HRT) will be used in subsequent FET cycles. On Day 3 of the menstrual cycle, we will measure the anxiety levels using the Chinese State-Trait Anxiety Inventory and serum E2, cortisol levels will be checked on the same day.

Recruited women having the first FET cycle following a freeze all strategy will be randomly assigned on the day of blastocyst(s) freezing according to a computer-generated randomization list into one of the following two groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
828
Inclusion Criteria
  1. Women aged 20-40 years at the time of IVF/ICSI
  2. Women undergoing their first FET of the first IVF cycle following a freeze-all strategy
  3. Undergoing IVF with GnRH antagonist
  4. At least one frozen blastocyst
Exclusion Criteria
  1. Severe ovarian hyperstimulation syndrome during the first IVF/ICSI cycle
  2. Preimplantation genetic testing
  3. Use of donor oocytes
  4. Presence of untreated hydrosalpinx or endometrial polyp on scanning during ovarian stimulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Immediate FET groupImmediate FETFET will be performed in the first menstrual cycle following the stimulated IVF cycle
Delayed FET groupDelayed FETFET will be performed in the second menstrual cycle following the stimulated IVF cycle
Primary Outcome Measures
NameTimeMethod
live birth1 year after FET

deliveries ≥22 weeks gestation with heartbeat and breath

Secondary Outcome Measures
NameTimeMethod
implantation rate6 weeks' gestation

the number of gestational sacs per blastocyst transferred

ectopic pregnancyectopic pregnancy during 12 weeks gestation

pregnancy outside the uterine cavity

ongoing pregnancy12 weeks' gestation

a viable pregnancy beyond 12 weeks' gestation

positive hCG2 weeks after FET

serum β-hCG ≥10 mIU/mL

clinical pregnancy6 weeks' gestation

presence of intrauterine gestational sac by trans-vaginal ultrasound at 6 gestational weeks.

miscarriage1 year after FET

a clinically recognized pregnancy loss before the 22 weeks of pregnancy

multiple pregnancymultiple pregnancy beyond gestation 12 weeks

more than one intrauterine sacs on scanning

birthweight of newborns1 year after FET

the birth weight of newborns

Trial Locations

Locations (1)

Shanghai JiAi Genetics & IVF Institute

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath